Carroll Financial Associates’s Sonnet BioTherapeutics SONN Stock Holding History

Carroll Financial Associates’s Portfolio SONN Stock Details SONN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Hold	0	–	–	–	1908
2021 Q3	–	Hold	0	–	–	–	1933
2021 Q2	–	Hold	0	–	–	–	1844
2021 Q1	–	Hold	0	–	–	–	1758
2020 Q4	–	Hold	0	–	–	–	1652
2020 Q3	–	Hold	0	–	–	–	1658
2020 Q2	–	Hold	0	–	–	–	1675
2020 Q1	–	Hold	0	–	–	–	1652
2019 Q4	–	Hold	0	–	–	–	1678
2019 Q3	–	Hold	0	–	–	–	1695
2019 Q2	–	Hold	0	–	–	–	1704
2019 Q1	–	Hold	0	–	–	–	1493
2018 Q4	–	Hold	0	–	–	–	1392
2018 Q3	–	Hold	0	–	–	–	1361
2018 Q2	–	Hold	0	–	–	–	1326
2018 Q1	–	Hold	0	–	–	–	1339
2017 Q2	–	Hold	0	–	–	–	1243
2017 Q1	–	Hold	0	–	–	–	1235
2016 Q4	–	Hold	0	–	–	–	1106

Other funds holding SONN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return